Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk
manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac …

Heart failure (HF) is a major health-care problem and the prognosis of affected patients is
poor. HF often coexists with a number of comorbidities of which declining renal function is of …

Background: Dapagliflozin reduces the risk of end-stage renal disease in patients with
chronic kidney disease. We examined the relative risk of cardiovascular and renal events in …

Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …

Background. Cigarette smoking has been established as a major risk factor for chronic
kidney disease (CKD) development in people with diabetes. Conflicting evidence exists …

Art. 1.1475/ringraziamenti Page 1 European Review for Medical and Pharmacological Sciences
2918 Abstract. – Cardiovascular disease (CVD), the leading cause of death, is mostly …

Despite improvements in pharmacotherapy, morbidity and mortality rates in community-
based populations with chronic heart failure still remain high. The increase in medical …

Patients with chronic kidney disease (CKD) are prone to developing cardiac hypertrophy
and fibrosis, which is associated with increased fibroblast growth factor 23 (FGF23) serum …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Cardiorenal syndrome includes a spectrum of disorders of the kidneys and heart in which
loss of function in one organ contributes to reduced function in the other organ. Cardiorenal …